Synthomer (SYNT) Competitors GBX 63.20 +0.20 (+0.32%) As of 11:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock SYNT vs. SCPA, ESNT, ZTF, TET, IOF, HAYD, WCH, ITX, DCTA, and HDDShould you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Scapa Group (SCPA), Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry. Synthomer vs. Its Competitors Scapa Group Essentra Zotefoams Treatt Iofina Haydale Graphene Industries Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Hardide Synthomer (LON:SYNT) and Scapa Group (LON:SCPA) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation. Does the media prefer SYNT or SCPA? In the previous week, Synthomer had 25 more articles in the media than Scapa Group. MarketBeat recorded 25 mentions for Synthomer and 0 mentions for Scapa Group. Synthomer's average media sentiment score of 0.33 beat Scapa Group's score of 0.00 indicating that Synthomer is being referred to more favorably in the media. Company Overall Sentiment Synthomer Neutral Scapa Group Neutral Do institutionals and insiders believe in SYNT or SCPA? 43.8% of Synthomer shares are owned by institutional investors. 28.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, SYNT or SCPA? Scapa Group has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Scapa Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynthomer£1.87B0.06-£82.04M-£49.90-1.27Scapa Group£281.80M0.00N/A-£29.30N/A Is SYNT or SCPA more profitable? Scapa Group has a net margin of 0.00% compared to Synthomer's net margin of -4.40%. Scapa Group's return on equity of 0.00% beat Synthomer's return on equity.Company Net Margins Return on Equity Return on Assets Synthomer-4.40% -7.52% -0.28% Scapa Group N/A N/A N/A Do analysts recommend SYNT or SCPA? Synthomer presently has a consensus target price of GBX 160, indicating a potential upside of 153.16%. Given Synthomer's stronger consensus rating and higher possible upside, equities research analysts plainly believe Synthomer is more favorable than Scapa Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synthomer 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummarySynthomer beats Scapa Group on 9 of the 13 factors compared between the two stocks. Get Synthomer News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYNT vs. The Competition Export to ExcelMetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£103.63M£8.11B£3.26B£3.07BDividend Yield28.47%3.52%5.20%5.02%P/E Ratio-1.2712.19105.85167.81Price / Sales0.0658.9131,322,622,491,820,400.00340,578.77Price / Cash2.2819.2523.8927.97Price / Book0.094.535.994.55Net Income-£82.04M£220.83M£148.72M£5.90B7 Day Performance-25.12%-0.98%2.24%0.75%1 Month Performance-32.69%-0.45%3.24%11.48%1 Year Performance-73.25%-3.01%35.31%69.41% Synthomer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYNTSynthomer3.1159 of 5 starsGBX 63.20+0.3%GBX 160+153.2%-74.4%£103.63M£1.87B-1.274,200Trending NewsEarnings ReportAnalyst ForecastInsider TradeHigh Trading VolumeSCPAScapa GroupN/AN/AN/AN/A£402.98M£281.80M-7.321,461ESNTEssentra2.1654 of 5 starsGBX 101.80-1.0%GBX 191.67+88.3%-34.7%£292.61M£309.74M83.86350ZTFZotefoamsN/AGBX 332+19.4%N/A-33.0%£159.69M£131.66M16.07549News CoverageEarnings ReportGap UpHigh Trading VolumeTETTreattN/AGBX 207.50-0.7%GBX 450+116.9%-53.0%£125.46M£142.31M11.21350Dividend IncreaseIOFIofinaN/AGBX 26+6.1%GBX 37.50+44.2%+25.3%£62.42M£61.34M18.2595HAYDHaydale Graphene IndustriesN/AGBX 0.64-2.2%N/A+79.7%£23.91M£14.20M-1.3367Gap DownWCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 133.85-0.5%GBX 325+142.8%-18.9%£18.05M£5.28M-12.1117Gap DownDCTADirecta PlusN/AGBX 10.95+4.3%N/A-39.7%£14.73M£20.29M-1.95187News CoverageInsider TradeGap UpHDDHardideN/AGBX 7.78+0.4%N/A+18.7%£6.13M£6.11M-3.2546Gap Down Related Companies and Tools Related Companies Scapa Group Alternatives Essentra Alternatives Zotefoams Alternatives Treatt Alternatives Iofina Alternatives Haydale Graphene Industries Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Directa Plus Alternatives Hardide Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SYNT) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthomer plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synthomer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
